Related Experiment Videos
4-Nitroquinoline-1-oxide: factors determining its mutagenicity in bacteria
Abstract:
In bacteria, 4-nitroquinoline-1-oxide (NQO) causes primarily mutations of the base-substitution type although frameshift mutations are also induced. The adducts formed are presumably recognized by error-prone DNA repair enzymes as evidenced by the much greater activity in plasmid pKM101-bearing tester strains. Although reduction of the nitro group appears to be required for mutagenic activity, this reduction is not catalyzed by the nitroreductase required for the demonstration of the mutagenicity in bacteria of other nitro-containing mutagens (nitrofurans, 2-nitronaphthalene, nitrofluorenes). The reduction of the nitro group appears to be catalyzed by a different nitroreductase. The mutagenicity of the non-carcinogenic 3-methyl-4-nitroquinoline-1-oxide (meNQO) may be related to this newly recognized nitroreductase. It is proposed, further, that the ultimate mutagenic intermediates derived from NQO and MeNQO differ.
Insights
4-nitroquinoline-1-oxide (NQO) causes DNA mutations in bacteria, requiring nitro group reduction by a specific nitroreductase. This mechanism differs from other mutagens, suggesting unique mutagenic intermediates for NQO and related compounds.
Area of Science:
- Microbiology
- Molecular Biology
- Toxicology
Background:
- 4-nitroquinoline-1-oxide (NQO) is a mutagenic agent in bacteria, inducing base-substitution and frameshift mutations.
- The mutagenicity of NQO is linked to DNA adduct formation and recognition by error-prone DNA repair systems, particularly evident in strains with plasmid pKM101.
- While nitro group reduction is essential for NQO's mutagenic activity, it is not mediated by the same nitroreductase enzymes that activate other nitro-containing mutagens.
Purpose of the Study:
- To investigate the specific nitroreductase responsible for activating 4-nitroquinoline-1-oxide (NQO) in bacterial mutagenicity assays.
- To elucidate the mechanism of NQO-induced mutagenesis, differentiating it from other known nitro-mutagens.
- To explore the potential role of a newly identified nitroreductase in the mutagenicity of NQO and its non-carcinogenic analog, 3-methyl-4-nitroquinoline-1-oxide (MeNQO).
Main Methods:
- Bacterial mutagenicity testing using tester strains, including those harboring plasmid pKM101.
- Analysis of DNA adduct formation and repair enzyme interactions.
- Enzymatic assays to identify and characterize the nitroreductase involved in NQO activation.
Main Results:
- NQO induces primarily base-substitution mutations in bacteria, with some frameshift mutations also observed.
- The mutagenicity of NQO is significantly enhanced in plasmid pKM101-bearing strains, indicating involvement of error-prone repair.
- A distinct nitroreductase, different from those activating other nitro-compounds, appears to catalyze the essential nitro group reduction for NQO mutagenicity.
- The mutagenicity of 3-methyl-4-nitroquinoline-1-oxide (MeNQO) may involve this newly identified nitroreductase.
Conclusions:
- The mutagenic activation of 4-nitroquinoline-1-oxide (NQO) in bacteria relies on a specific nitroreductase system distinct from those of other nitro-mutagens.
- Error-prone DNA repair pathways play a crucial role in processing NQO-induced DNA damage.
- It is proposed that NQO and MeNQO are converted into different ultimate mutagenic intermediates through distinct enzymatic pathways.